ICIG Acquires Sandoz Site in Germany
PTSM: Pharmaceutical Technology Sourcing and Management
ICIG’s CordenPharma Group expands fermentation-based production technology with acquisition of Sandoz Site.
International Chemical Investors Group (ICIG), owner of CordenPharma, announced on Feb. 24, 2016 that it will acquire all of the shares in Sandoz Industrial Products, a Frankfurt-Höchst, Germany based manufacturer of enzyme-based fermentation products and intermediates for the pharmaceutical industry, especially for the use in antibiotics.
Sandoz Industrial Products will maintain its operations associated with the CordenPharma Group. The business will be complementary to ICIG’s pharma activities through CordenPharma as well as to its fine chemicals business in the WeylChem Group.
The site represents an important building block for further expansion into fermentation-based production technology for ICIG, the company reports. With the acquisition of the Sandoz Höchst site, CordenPharma Group will become one of the major suppliers of 7-ACA to customers worldwide, the company reports. CordenPharma will also use the material for its own antibiotics value chain at its Latina site in Italy.
The transaction is expected to close on April 1, 2016.
Source: CordenPharma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
